Background Patients with cancer are considered a priority group for Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of …

The SARS-Cov-2 pandemic in 2020 has caused oncology teams around the world to adapt
their practice in the aim of protecting patients. Early evidence from China indicated that …

Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …

Introduction Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to
be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from …

Background Oncological care was considerably impacted by the COVID-19 pandemic.
Worrisome declines in diagnostic procedures and cancer diagnoses in 2020 have been …

Background A systematic review and meta-analysis was performed to estimate mortality in
adult patients with solid or hematological malignancies and SARS-CoV-2 infection. Methods …

PURPOSE There are scarce data to aid in prognostication of the outcome of critically ill
cancer patients with COVID-19. In this systematic review and meta-analysis, we investigated …

Introduction The global pandemic of coronavirus disease 2019 (COVID‐19) is caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It seems that there is an …

The relationship between cancer and coronavirus disease 2019 (COVID‐19) infection and
severity remains poorly understood. We conducted a population‐based cohort study …

Background: Cancer patients, being immunocompromised, are at higher risk of coronavirus
disease (COVID-19). The current study determines cancer patients' knowledge, attitude …